Publication | Closed Access

The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease

Translational MedicineHepatic EncephalopathyHepatologyLiver PhysiologyHepatitisPathologyHepatotoxicityAcute Liver FailureLiver DiseaseAdditive ValueMedicineDrug-induced Liver InjuryCirrhosisEnd-stage Liver Disease